Cofactor-specific modulation of 11β-hydroxysteroid dehydrogenase 1 inhibitor potency

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1774, Issue 9, 2007, Pages 1184-1191

  Sahni Arya, Bhavana ^a   Flynn, Michael J ^a   Bergeron, Laurie ^a   Salyan, Mary Ellen K ^a   Pedicord, Donna L ^a   Golla, Rajasree ^a   Ma, Zhengping ^a   Wang, Haixia ^a   Seethala, Ramakrishna ^a   Wu, Shung C ^a   Li, James J ^a   Nayeem, Akbar ^a   Gates, Cynthia ^a   Hamann, Lawrence G ^a   Gordon, David A ^a   Blat, Yuval ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

11 HSD1; Glucocorticoid; Inhibitor

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; 11BETA HYDROXYSTEROID DEHYDROGENASE 1 INHIBITOR; CORTISONE; ENZYME INHIBITOR; HYDROCORTISONE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; OXIDOREDUCTASE; SULFONAMIDE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CONTROLLED STUDY; DRUG BINDING; DRUG EFFECT; DRUG POTENCY; DRUG STRUCTURE; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VIVO STUDY; MODULATION; PRIORITY JOURNAL; REACTION ANALYSIS;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; HUMANS; KINETICS; NADP; PYRIDINES; SULFONAMIDES; TRIAZOLES;

EID: 34548268002     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2007.07.005     Document Type: Article

References (38)

1. Bahr V., Pfeiffer A.F., and Diederich S. The metabolic syndrome X and peripheral cortisol synthesis. Exp. Clin. Endocrinol. Diabetes 110 (2002) 313-318
2. Seckl J.R., and Walker B.R. 11beta-hydroxysteroid dehydrogenase type 1 as a modulator of glucocorticoid action: from metabolism to memory. Trends Endocrinol. Metab. 15 (2004) 418-424
3. Tomlinson J.W., Walker E.A., Bujalska I.J., Draper N., Lavery G.G., Cooper M.S., Hewison M., and Stewart P.M. 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr. Rev. 25 (2004) 831-866
4. Kotelevtsev Y., Holmes M.C., Burchell A., Houston P.M., Schmoll D., Jamieson P., Best R., Brown R., Edwards C.R., Seckl J.R., and Mullins J.J. 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 14924-14929
5. Morton N.M., Holmes M.C., Fievet C., Staels B., Tailleux A., Mullins J.J., and Seckl J.R. Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice. J. Biol. Chem. 276 (2001) 41293-41300
6. Masuzaki H., Paterson J., Shinyama H., Morton N.M., Mullins J.J., Seckl J.R., and Flier J.S. A transgenic model of visceral obesity and the metabolic syndrome. Science 294 (2001) 2166-2170
7. Paterson J.M., Morton N.M., Fievet C., Kenyon C.J., Holmes M.C., Staels B., Seckl J.R., and Mullins J.J. Metabolic syndrome without obesity: hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 7088-7093
8. Andrews R.C., Rooyackers O., and Walker B.R. Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes. J. Clin. Endocrinol. Metab. 88 (2003) 285-291
9. Odermatt A., Arnold P., Stauffer A., Frey B.M., and Frey F.J. The N-terminal anchor sequences of 11beta-hydroxysteroid dehydrogenases determine their orientation in the endoplasmic reticulum membrane. J. Biol. Chem. 274 (1999) 28762-28770
10. Ozols J. Lumenal orientation and post-translational modifications of the liver microsomal 11 beta-hydroxysteroid dehydrogenase. J. Biol. Chem. 270 (1995) 10360
11. Lakshmi V., and Monder C. Purification and characterization of the corticosteroid 11 beta-dehydrogenase component of the rat liver 11 beta-hydroxysteroid dehydrogenase complex. Endocrinology 123 (1988) 2390-2398
12. Bujalska I.J., Kumar S., and Stewart P.M. Does central obesity reflect "Cushing's disease of the omentum"?. Lancet 349 (1997) 1210-1213
13. Jamieson P.M., Chapman K.E., Edwards C.R., and Seckl J.R. 11 beta-hydroxysteroid dehydrogenase is an exclusive 11 beta- reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations. Endocrinology 136 (1995) 4754-4761
14. Cooper M.S., Walker E.A., Bland R., Fraser W.D., Hewison M., and Stewart P.M. Expression and functional consequences of 11beta-hydroxysteroid dehydrogenase activity in human bone. Bone 27 (2000) 375-381
15. Hennebold J.D., and Daynes R.A. Inhibition of skin 11beta-hydroxysteroid dehydrogenase activity in vivo potentiates the anti-inflammatory actions of glucocorticoids. Arch. Dermatol. Res. 290 (1998) 413-419
16. Monder C., Miroff Y., Marandici A., and Hardy M.P. 11 beta-Hydroxysteroid dehydrogenase alleviates glucocorticoid-mediated inhibition of steroidogenesis in rat Leydig cells. Endocrinology 134 (1994) 1199-1204
17. Atanasov A.G., Nashev L.G., Schweizer R.A., Frick C., and Odermatt A. Hexose-6-phosphate dehydrogenase determines the reaction direction of 11beta-hydroxysteroid dehydrogenase type 1 as an oxoreductase. FEBS Lett. 571 (2004) 129-133
18. Draper N., Walker E.A., Bujalska I.J., Tomlinson J.W., Chalder S.M., Arlt W., Lavery G.G., Bedendo O., Ray D.W., Laing I., Malunowicz E., White P.C., Hewison M., Mason P.J., Connell J.M., Shackleton C.H., and Stewart P.M. Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nat. Genet. 34 (2003) 434-439
19. Jornvall H., Persson B., Krook M., Atrian S., Gonzalez-Duarte R., Jeffery J., and Ghosh D. Short-chain dehydrogenases/reductases (SDR), Biochemistry 34 (1995) 6003-6013
20. Oppermann U., Filling C., Hult M., Shafqat N., Wu X., Lindh M., Shafqat J., Nordling E., Kallberg Y., Persson B., and Jornvall H. Short-chain dehydrogenases/reductases (SDR): the 2002 update. Chem. Biol. Interact. 143-144 (2003) 247-253
21. Monder C., Lakshmi V., and Miroff Y. Kinetic studies on rat liver 11 beta-hydroxysteroid dehydrogenase. Biochim. Biophys. Acta 1115 (1991) 23-29
22. Shafqat N., Elleby B., Svensson S., Shafqat J., Jornvall H., Abrahmsen L., and Oppermann U. Comparative enzymology of 11 beta -hydroxysteroid dehydrogenase type 1 from glucocorticoid resistant (Guinea pig) versus sensitive (human) species. J. Biol. Chem. 278 (2003) 2030-2035
23. Walker E.A., Clark A.M., Hewison M., Ride J.P., and Stewart P.M. Functional expression, characterization, and purification of the catalytic domain of human 11-beta -hydroxysteroid dehydrogenase type 1. J. Biol. Chem. 276 (2001) 21343-21350
24. Hosfield D.J., Wu Y., Skene R.J., Hilgers M., Jennings A., Snell G.P., and Aertgeerts K. Conformational flexibility in crystal structures of human 11beta-hydroxysteroid dehydrogenase type I provide insights into glucocorticoid interconversion and enzyme regulation. J. Biol. Chem. 280 (2005) 4639-4648
25. Ogg D., Elleby B., Norstrom C., Stefansson K., Abrahmsen L., Oppermann U., and Svensson S. The crystal structure of guinea pig 11beta-hydroxysteroid dehydrogenase type 1 provides a model for enzyme-lipid bilayer interactions. J. Biol. Chem. 280 (2005) 3789-3794
26. Zhang J., Osslund T.D., Plant M.H., Clogston C.L., Nybo R.E., Xiong F., Delaney J.M., and Jordan S.R. Crystal structure of murine 11 beta-hydroxysteroid dehydrogenase 1: an important therapeutic target for diabetes. Biochemistry 44 (2005) 6948-6957
27. Kim K.W., Wang Z., Busby J., Tsuruda T., Chen M., Hale C., Castro V.M., Svensson S., Nybo R., Xiong F., and Wang M. The role of tyrosine 177 in human 11beta-hydroxysteroid dehydrogenase type 1 in substrate and inhibitor binding: an unlikely hydrogen bond donor for the substrate. Biochim. Biophys. Acta 1764 (2006) 824-830
28. Kim K.W., Wang Z., Busby J., Tsuruda T., Chen M., Hale C., Castro V.M., Svensson S., Nybo R., Xiong F., and Wang M. The selectivity of tyrosine 280 of human 11beta-hydroxysteroid dehydrogenase type 1 in inhibitor binding. FEBS Lett. 581 (2007) 995-999
29. Olson S., Aster S.D., Brown K., Carbin L., Graham D.W., Hermanowski-Vosatka A., LeGrand C.B., Mundt S.S., Robbins M.A., Schaeffer J.M., Slossberg L.H., Szymonifka M.J., Thieringer R., Wright S.D., and Balkovec J.M. Adamantyl triazoles as selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1. Bioorg. Med. Chem. Lett. 15 (2005) 4359-4362
30. I.H. Segel, Enzyme Kinetics, ed., John Wiley and Sons, Inc. 1993.
31. Hermanowski-Vosatka A., Balkovec J.M., Cheng K., Chen H.Y., Hernandez M., Koo G.C., Le Grand C.B., Li Z., Metzger J.M., Mundt S.S., Noonan H., Nunes C.N., Olson S.H., Pikounis B., Ren N., Robertson N., Schaeffer J.M., Shah K., Springer M.S., Strack A.M., Strowski M., Wu K., Wu T., Xiao J., Zhang B.B., Wright S.D., and Thieringer R. 11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice. J. Exp. Med. 202 (2005) 517-527
32. Betz G., and Taylor P. Reaction mechanism of 20 beta-hydroxysteroid dehydrogenase determined by equilibrium rate exchange. Arch. Biochem. Biophys. 137 (1970) 109-114
33. Brandt M., and Levy M.A. 3 Beta-hydroxy-delta 5-steroid dehydrogenase/3-keto-delta 5-steroid isomerase from bovine adrenals: mechanism of inhibition by 3-oxo-4-aza steroids and kinetic mechanism of the dehydrogenase. Biochemistry 28 (1989) 140-148
34. Rauz S., Cheung C.M., Wood P.J., Coca-Prados M., Walker E.A., Murray P.I., and Stewart P.M. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 lowers intraocular pressure in patients with ocular hypertension. QJM 96 (2003) 481-490
35. Sandeep T.C., Yau J.L., MacLullich A.M., Noble J., Deary I.J., Walker B.R., and Seckl J.R. 11Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 6734-6739
36. Arampatzis S., Kadereit B., Schuster D., Balazs Z., Schweizer R.A., Frey F.J., Langer T., and Odermatt A. Comparative enzymology of 11beta-hydroxysteroid dehydrogenase type 1 from six species. J. Mol. Endocrinol. 35 (2005) 89-101
37. Hult M., Shafqat N., Elleby B., Mitschke D., Svensson S., Forsgren M., Barf T., Vallgarda J., Abrahmsen L., and Oppermann U. Active site variability of type 1 11beta-hydroxysteroid dehydrogenase revealed by selective inhibitors and cross-species comparisons. Mol. Cell. Endocrinol. 248 (2006) 26-33
38. Bujalska I.J., Walker E.A., Hewison M., and Stewart P.M. A switch in dehydrogenase to reductase activity of 11 beta-hydroxysteroid dehydrogenase type upon differentiation of human omental adipose stromal cells. J. Clin. Endocrinol. Metab. 87 (2002) 1205-1210